Literature DB >> 24558086

Long-term efficacy of glibenclamide and sitagliptin therapy in adult patients with KCNJ11 permanent diabetes.

Julia Sastre1, Alessandra Luque, Florentino del Val, Angel Aragonés, José López.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24558086     DOI: 10.2337/dc13-2280

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  2 in total

Review 1.  Precision Medicine: Long-Term Treatment with Sulfonylureas in Patients with Neonatal Diabetes Due to KCNJ11 Mutations.

Authors:  Lisa R Letourneau; Siri Atma W Greeley
Journal:  Curr Diab Rep       Date:  2019-06-27       Impact factor: 4.810

2.  Successful Use of a GLP-1 Receptor Agonist as Add-on Therapy to Sulfonylurea in the Treatment of KCNJ11 Neonatal Diabetes.

Authors:  Morten Hindsø; Christoffer Martinussen; Maria Saur Svane; Simon Veedfald; Birthe Gade-Rasmussen; Torben Hansen; Sten Madsbad
Journal:  Eur J Case Rep Intern Med       Date:  2021-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.